Regulatory & Legal Updates: New Rules Affecting Your Credit and Loans in 2025

The Consumer Financial Protection Bureau issued more final rules in 2024 than in any single year since its founding under the Dodd-Frank Act in 2011. Several of these rules directly affect the terms and costs of borrowing, the content of credit reports, and the rights consumers have when disputing inaccurate information. Others are being contested in federal courts, which means the regulatory status of certain consumer protections depends on which circuit you're in and which district court has jurisdiction over the active lawsuits. Knowing which rules are in effect, which are stayed, and which are newly finalized is essential context for anyone making credit decisions in 2025.

The regulatory environment for consumer finance is more contested in 2025 than at any point since 2017. Industry groups including the American Bankers Association, the U.S. Chamber of Commerce, and the Consumer Bankers Association have filed lawsuits challenging at least six major CFPB rules. Some of those challenges have succeeded in obtaining preliminary injunctions that block implementation; others have failed. The political context matters: a change in administration affects CFPB leadership and enforcement priorities, and several rules finalized in late 2024 could be subject to Congressional Review Act challenges or scaled-back enforcement under a different director.

Section 1033 Open Banking Rule and What It Means for Consumers

The CFPB's Personal Financial Data Rights Rule, finalized in October 2024, requires banks, credit card issuers, and digital payment platforms to provide consumers with the right to access and share their own financial data through standardized APIs. The rule applies to institutions covered under Section 1033 of the Dodd-Frank Act. Implementation is phased: the largest banks (those with over $500 billion in assets) must comply by April 2026, followed by progressively smaller institutions through 2030. The practical consumer benefit is that you'll be able to authorize fintech apps, alternative lenders, and financial advisors to access your real-time account data — income, transaction history, cash flow — without handing over your banking username and password. This eliminates the screen-scraping security vulnerability that current Plaid-dependent apps rely on.

The rule's lending implications are significant. Alternative lenders will be able to access verified cash flow data with consumer permission, potentially enabling loan underwriting based on actual income and payment behavior rather than traditional credit file data alone. This matters for the approximately 26 million Americans classified as credit invisible (no usable credit file) and another 19 million with thin files who currently can't qualify for most conventional lending products. The Financial Data Exchange (FDX) — a standards body whose members include JPMorgan Chase, Wells Fargo, and Bank of America — has been building the API infrastructure that will support this rule's implementation, with several major banks already operating compliant data-sharing APIs ahead of the deadline.

Medical Debt Credit Reporting Ban and FCRA Reform Efforts

The CFPB's final rule prohibiting medical debt from appearing on credit reports — published in January 2025 — represents the most significant change to the Fair Credit Reporting Act framework since the FACT Act of 2003. The rule covers all medical and healthcare debt, regardless of amount. The CFPB's research found that medical debt is a poor predictor of a borrower's likelihood to repay other types of credit (its predictive validity is significantly lower than credit card or mortgage payment history), making its inclusion on credit reports a questionable practice that disproportionately harms people who faced unexpected health crises. Approximately 15 million Americans carry medical collections, and the CFPB estimated the rule would raise affected consumers' credit scores by an average of 20 points.

The credit reporting industry — primarily the three major bureaus, Experian, Equifax, and TransUnion — challenged the medical debt rule in federal court in early 2025, arguing the CFPB exceeded its statutory authority under the FCRA. Separately, a bipartisan group of senators introduced the Medical Debt Relief Act of 2025 to codify the ban in statute rather than regulation, which would make it harder to reverse through administrative action. For consumers: FICO Score 9 and VantageScore 4.0 already discount medical collections in their calculations, and many lenders using these models are effectively ignoring medical debt even before the regulatory ban fully takes effect. Checking which scoring model your lender uses is worth a quick inquiry before applying.

SECURE 2.0 Retirement Provisions Taking Effect in 2025

While primarily a retirement law rather than a credit law, SECURE 2.0's 2025 provisions affect the financial decisions of millions of borrowers. The mandatory automatic enrollment provision — requiring new 401(k) and 403(b) plans established after December 29, 2022 to automatically enroll eligible employees at a minimum 3% contribution rate starting in January 2025 — is expected to increase plan participation by an estimated 5 to 8 percentage points at affected employers. The emergency savings account provision allows employers to offer an "emergency sidecar" account linked to the 401(k), allowing contributions of up to $2,500 that can be withdrawn penalty-free for emergencies. This directly addresses the documented pattern where unexpected expenses cause people to take 401(k) hardship distributions, triggering taxes and the 10% early withdrawal penalty.

SECURE 2.0 also expanded the student loan match provision starting in 2024: employers can now make matching 401(k) contributions based on an employee's student loan payments, even if the employee contributes nothing to the 401(k) itself. This allows borrowers prioritizing debt payoff to still receive employer match dollars — a previously unavailable option. The IRS issued guidance on implementation in August 2024, and several large employers including Abbott Laboratories (which pioneered a similar private program before SECURE 2.0 codified it) have already rolled out the feature. Employees should ask their HR or benefits administrator whether their employer has adopted this provision, as it is optional and adoption rates vary significantly across industries.